A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. [electronic resource]
Producer: 20131126Description: 1605-12 p. digitalISSN:- 1468-2060
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibody Formation
- Antirheumatic Agents -- adverse effects
- Double-Blind Method
- Female
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Male
- Middle Aged
- Prospective Studies
- Severity of Illness Index
- Spondylitis, Ankylosing -- blood
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.